Apollomics Inc. (APLM)
(Delayed Data from NSDQ)
$0.16 USD
-0.01 (-3.66%)
Updated Oct 4, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Apollomics Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1 | 1 | 1 | 2 | NA |
Cost Of Goods | 0 | 0 | 0 | 0 | NA |
Gross Profit | 1 | 1 | 1 | 2 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 52 | 46 | 51 | 42 | 0 |
Income After Depreciation & Amortization | -51 | -45 | -50 | -40 | 0 |
Non-Operating Income | -122 | -196 | -45 | -35 | NA |
Interest Expense | 0 | 0 | 0 | 0 | NA |
Pretax Income | -173 | -241 | -95 | -75 | NA |
Income Taxes | 0 | 0 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -173 | -241 | -95 | -75 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -173 | -241 | -95 | -75 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -50 | -44 | -49 | -40 | 0 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | NA |
Income After Depreciation & Amortization | -51 | -45 | -50 | -40 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 74.40 | 390.94 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -2.32 | -0.62 | NA | NA | NA |
Diluted Net EPS (GAAP) | -2.32 | -0.62 | -0.23 | NA | NA |
Fiscal Year end for Apollomics Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |